The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses. ...

Following the recent drug rescheduling from the Trump Administration, medicinal marijuana companies are preparing to raise ...

Nearly 13 percent of Americans are using medications or marijuana to help them fall asleep at night, new federal data reveals ...

Legal rules around medical marijuana have been loosened, following an April 23 order from the Acting U.S. Attorney General ...

Indiana Gov. Mike Braun has expressed a willingness to consider legalizing marijuana, citing the potential for increased tax ...

The federal government no considers medical marijuana to be as addictive or dangerous as heroin or cocaine, following a ...

The DOJ is loosening federal regulations on medicinal marijuana, moving it from Schedule I to Schedule III, allowing tax ...

The move will bring enormous tax benefits to medical marijuana producers and may speed research into its effects, experts say ...

Acting Attorney General Todd Blanche said he is immediately moving medical marijuana from Schedule I to Schedule III, which ...

District Superintendent Nikolai Vitti said consumption of edibles by youths has been 'an ongoing and increasing challenge' since pot legalization.

A key congressional panel has voted to block the federal rescheduling of marijuana—even though the Trump administration ...

The order places FDA-approved products containing marijuana and state-regulated medical marijuana products at a lower drug ...